Ferric carboxymaltose for treatment of iron deficiency and iron deficiency anemia caused by abnormal uterine bleeding

Ferric carboxymaltose for treatment of iron deficiency and iron deficiency anemia caused by abnormal uterine bleeding

Bibliographic Details
Main Authors:	Ahmed Hagras, Naglaa Ali Hussein, Ibrahim Abdelazim, Nareman Elhamamy
Format:	Article
Language:	English
Published:	Termedia Publishing House 2022-12-01
Series:	Menopause Review
Subjects:	ferric carboxy maltose (fcm) iron deficiency (id) iron deficiency anemia (ida) abnormal uterine bleeding (aub).
Online Access:	https://www.termedia.pl/Ferric-carboxymaltose-for-treatment-of-iron-deficiency-and-iron-deficiency-anemia-caused-by-abnormal-uterine-bleeding,4,49870,1,1.html

Similar Items

Efficacy of ferric carboxy maltose in treatment of iron deficiency/iron deficiency anaemia during pregnancy
by: Mariam Obaid, et al.
Published: (2023-03-01)

Parenteral iron therapy for anaemia in pregnancy: ferric carboxy maltose versus iron sucrose
by: Sudha R, et al.
Published: (2022-07-01)

Acute hypersensitivity reaction following intravenous ferric carboxymaltose injection for iron deficiency anaemia: a case report.
by: Neeraj Kumar, et al.
Published: (2023-03-01)

Iron Deficiency: A New Target for Patients With Heart Failure
by: Caterina Rizzo, et al.
Published: (2021-08-01)

Iron deficiency anemia with menorrhagia: Ferric carboxymaltose a safer alternative to blood transfusion
by: Vineet Mishra, et al.
Published: (2018-01-01)

Ferric carboxymaltose in patients with pulmonary arterial hypertension and iron deficiency: a long‐term study
by: Tilmann Kramer, et al.
Published: (2021-12-01)

A comparative study of ferric carboxymaltose and iron sucrose as a parenteral iron treatment in iron deficiency anemia during pregnancy in a tertiary care hospital
by: Sandip Kumar Ghosh, et al.
Published: (2024-04-01)

Effectiveness and safety of ferric carboxymaltose compared to iron sucrose in women with iron deficiency anemia: phase IV clinical trials
by: Amreen Naqash, et al.
Published: (2018-01-01)

Seven-Year Single-Center Experience of the Efficacy and Safety of Ferric Carboxymaltose in Cancer Patients with Iron-Deficiency Anemia
by: Burak Yasin Aktaş, et al.
Published: (2023-11-01)

Efficacy and safety of ferric carboxymaltose versus ferrous sulfate for iron deficiency anemia during pregnancy: subgroup analysis of Korean women
by: Jae-Yoon Shim, et al.
Published: (2018-08-01)

Intravenous ferric carboxymaltose for the treatment of iron deﬁciency anemia
by: João Ricardo Friedrisch, et al.
Published: (2015-12-01)

Efficacy and safety of intravenous ferric carboxymaltose in iron deficiency anemia; Real-life data from Turkey, a single center experience
by: Ali Eser, et al.
Published: (2021-06-01)

Efficacy and Safety of Intravenous Ferric Carboxymaltose Treatment of Iron Deficiency Anaemia in Patients with Corpus Atrophic Gastritis: A Retrospective Study
by: Ludovica Dottori, et al.
Published: (2023-09-01)

Patient-Reported Outcomes After Ferric Carboxymaltose Treatment for Iron Deficiency Anemia: A Prospective Observational Study
by: Kwong WJ, et al.
Published: (2023-08-01)

Budget Impact of Intravenous Iron Therapy with Ferric Carboxymaltose in Patients with Chronic Heart Failure and Iron Deficiency in Romania
by: Lorenzovici László, et al.
Published: (2019-12-01)

Ferric carboxymaltose solution versus iron sucrose complex in treating Iron-deficiency anemia patients with heavy uterine bleeding: A cost-efficacy study from a tertiary care hospital in the Kingdom of Saudi Arabia
by: Ayman Hejazi, et al.
Published: (2021-01-01)

Hypophosphatemia after high-dose iron repletion with ferric carboxymaltose and ferric derisomaltose—the randomized controlled HOMe aFers study
by: I. E. Emrich, et al.
Published: (2020-07-01)

Efficacy and Safety of Ferric Carboxymaltose in the Management of Iron Deficiency Anemia: A Multi-Center Real-World Study from India
by: Charmila A, et al.
Published: (2022-06-01)

Ferric Carboxymaltose in Patients with Acute Decompensated Heart Failure and Iron Deficiency: A Real-Life Study
by: Federico Capone, et al.
Published: (2023-08-01)

Ferric Carboxymaltose Improves the Quality of Life of Patients with Inflammatory Bowel Disease and Iron Deficiency without Anaemia
by: Jose María Huguet, et al.
Published: (2022-05-01)

Cost-minimization analysis in iron-deficiency anemia comparing intravenous ferric carboxymaltose to standard of care in pregnant women in Algeria
by: Lama Aladham, et al.
Published: (2023-01-01)

Incidence of Hypophosphatemia after Ferric Carboxymaltose Treatment: Single Center Experience
by: Esra TERZİ DEMİRSOY
Published: (2021-08-01)

Effects of Iron Supplementation on Hemoglobin Concentration in 12-18 Month Old Iron-Deficient Anemic Infants
by: Iskandar Iskandar, et al.
Published: (2018-12-01)

Mutation Analysis in Iron Deficiency Anemia of Undeterminable Etiology
by: Banu Çiçek Yalçın Dulundu, et al.
Published: (2016-12-01)

Relationship between Helicobacter pylori infection and iron deficiency anemia in children: A review article
by: Khaled Abdalla Abdelbaseer, et al.
Published: (2023-01-01)

Comparison of the use of intravenous iron sucrose with intravenous ferric Carboxymaltose for treatment of iron deficiency anaemia in pregnant patients
by: Khar un-Nisa, et al.
Published: (2022-11-01)

Symptomatic severe hypophosphatemia after intravenous ferric carboxymaltose
by: Wendy Fang, et al.
Published: (2019-10-01)

Iron deficiency and iron deficiency anemia in the adult omani population
by: Salam Alkindi, et al.
Published: (2018-01-01)

Ferric carboxymaltose for the treatment of iron‐deficient heart failure patients: a systematic review and meta‐analysis
by: Muhammad Shahzeb Khan, et al.
Published: (2020-12-01)

Short‐term changes in left and right systolic function following ferric carboxymaltose: a substudy of the Myocardial‐IRON trial
by: Enrique Santas, et al.
Published: (2020-12-01)

Iron Deficiency Anemia in Primary School Children in Beni-Suef (Prevalence and Clinical Spectrum)
by: Amna Mabrouk, et al.
Published: (2022-07-01)

Comparative safety of intravenous Ferumoxytol versus Ferric Carboxymaltose for the Treatment of Iron Deficiency Anemia: rationale and study design of a randomized double-blind study with a focus on acute hypersensitivity reactions
by: Adkinson NF, et al.
Published: (2017-09-01)

New Era in the Treatment of Iron Deficiency Anaemia Using Trimaltol Iron and Other Lipophilic Iron Chelator Complexes: Historical Perspectives of Discovery and Future Applications
by: George J. Kontoghiorghes, et al.
Published: (2021-05-01)

Safety and effectiveness of ferric carboxymaltose intravenous therapy in pediatric patients with chronic kidney disease
by: Patricia Garcia-Ortega, et al.
Published: (2022-10-01)

Prevalence of iron-deficiency anemia in pregnant women with various thalassemia genotypes: Thoughts on iron supplementation in pregnant women with thalassemia genes
by: Min Wang, et al.
Published: (2022-11-01)

Fatal anaphylactic reaction due to ferric carboxymaltose: A case report
by: Aylin Mualla Arici, et al.
Published: (2020-07-01)

Corrigendum: Prevalence of iron-deficiency anemia in pregnant women with various thalassemia genotypes: thoughts on iron supplementation in pregnant women with thalassemia genes
by: Min Wang, et al.
Published: (2023-08-01)

Evaluation of Minimal Optimal Dose of Intravenous Ferric Carboxymaltose for Treatment of Iron Deficiency Anemia and Risk of Transient Hyperferritinemia
by: Alharbi AA, et al.
Published: (2022-11-01)

Switching iron sucrose to ferric carboxymaltose associates to better control of iron status in hemodialysis patients
by: Jesse M. G. Hofman, et al.
Published: (2018-09-01)

Profile of iron deficiency anemia among junior high school students
by: Dewi Iriani, et al.
Published: (2001-04-01)